Get 20% lifetime commission for referring investors to digrin.com
here.
Protara Therapeutics, Inc. ( TARA) - Key Metrics
TARA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.36 | -$0.23 | -$0.24 |
| 2026Q1 | $0 | -$0.31 | -$0.37 | -$0.37 |
| 2025Q4 | $0 | -$0.38 | -$0.37 | -$0.37 |
| 2025Q3 | $0 | -$0.31 | -$0.29 | -$0.29 |
| 2025Q2 | $0 | -$0.35 | -$0.29 | -$0.29 |
TARA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.65 |
| 2026Q1 | 0% | -4.20 |
| 2025Q4 | 0% | -3.51 |
| 2025Q3 | 0% | -3.51 |
| 2025Q2 | 0% | -2.16 |
TARA
Price: $3.94
52 week price:
Earnings Per Share: -1.36 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2909
Market Capitalization: 234.6 million